Literature DB >> 78457

[Limits and possibilities of neoplasm immunotherapy].

R Kurth.   

Abstract

Immunological treatment of malignant human tumors has so far met with little success. Based on methods and insights obtained by investigation of corresponding animal models, this article attempts to elucidate the reasons for this failure and to suggest ways and means to improve immunotherapeutic approaches to human neoplasms.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 78457     DOI: 10.1007/BF00450586

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


  61 in total

Review 1.  Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

Authors:  K E Hellström; I Hellström
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

2.  Augmentation of cytotoxic drug action by antibodies directed at cell surface.

Authors:  R D Rubens; R Dulbecco
Journal:  Nature       Date:  1974-03-01       Impact factor: 49.962

3.  Demonstration of cell-mediated immunity to human neoplasms of various histological types.

Authors:  I Hellström; K E Hellström; H O Sjögren; G A Warner
Journal:  Int J Cancer       Date:  1971-01-15       Impact factor: 7.396

Review 4.  Tumor antigens.

Authors:  G Klein
Journal:  Annu Rev Microbiol       Date:  1966       Impact factor: 15.500

5.  [BCG in cancer therapy--wishful thinking or the therapy of the future?].

Authors:  W F Jungi
Journal:  Schweiz Med Wochenschr       Date:  1976-10-09

6.  Transformation by simian virus 40 of spleen cells from a hyperimmune rabbit: evidence for synthesis of immunoglobulin by the transformed cells.

Authors:  J J Collins; P H Black; A D Strosberg; E Haber; K J Bloch
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

7.  Immunotherapy of cancer with antibody.

Authors:  H S Shin; G R Pasternack; J S Economou; R J Johnson; M L Hayden
Journal:  Science       Date:  1976-10-15       Impact factor: 47.728

8.  An examination of the immunology of cancer patients.

Authors:  A J Cochran; R M Mackie; R M Grant; C E Ross; M D Connell; G Sandilands; K Whaley; D E Hoyle; A M Jackson
Journal:  Int J Cancer       Date:  1976-09-15       Impact factor: 7.396

9.  Neuraminidase and tumor immunotherapy.

Authors:  H H Sedlacek; F R Seiler; H G Schwick
Journal:  Klin Wochenschr       Date:  1977-03-01

10.  Leukemia-associated antigens detected by heterologous antisera.

Authors:  A Durantez; J Zighelboim; R P Gale
Journal:  J Natl Cancer Inst       Date:  1976-06       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.